Figure 5From: Radiosynthesis and preclinical evaluation of [11C]prucalopride as a potential agonist PET ligand for the 5-HT4 receptor Summed (0 to 45 min after injection) whole body PET images following IV injection of [11 C]prucalopride in rat. (left) Baseline and after (right) pre-treatment with tariquidar (15 mg·kg−1 IV). Arrows indicate the (a) brain region, (b) lungs, (c) spine, (d) stomach, (e) liver, (f) jejunum, (g) caecum, and (h) bladder.Back to article page